Human Gene Therapy

Editor-in-Chief: Terence R. Flotte, MD
Deputy Editor-in-Chief: Guangping Gao, PhD
European Editor: Hildegard Büning, PhD
Asian Editor: Yu-Quan Wei MD, PhD
Deputy Editors: Mark Kay, MD, PhD, Thierry VandenDriessche, PhD, and Cheng Seng, PhD

ISSN: 1043-0342 | Online ISSN: 1557-7422 | Published Monthly in 12 Double Issues | Current Volume: 31

Impact Factor: 4.510 2019 Journal Citation Reports (Clarivate, 2020)

CiteScore™: 6.8

The first peer-reviewed journal in the field of human gene therapy, providing all-inclusive coverage of the research, methods, and clinical developments that are driving today's explosion of gene therapy advances.

View Aims & Scope

Search Subscribe/Renew Recommend This Title Sign Up for TOC Alerts Submit a Paper Share with a Colleague

Announcements

New eBook: “All in One” 24/7 home cage monitoring: Improving model translation, animal welfare and data reproducibility

Free Download: Roundtable Discussion on Leaps in Innovation in Cancer Immunology

Also of Interest to the HGT Community:
- Now On Demand! Free Webinar on Home-Cage Monitoring 24/7: Improving Research Reproducibility and Outcomes...Register Now
- Expert Roundtable: Home-Cage Monitoring and its Effects on Research Capability and Outcomes
- Gene and Cell Therapy Connect - a free, comprehensive news source delivered bimonthly to readers. Sign up or View the archive

Featured Content

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.